| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 399 | 409 | 393 | 374 | 432 | 440 | 415 | 387 | 448 | 370 | 434 | 434 | 558 | 418 | 442 | 454 | 528 | 427 | 480 | 426 | 398 | 437 | 509 | 483 | 499 | 530 | 590 | 543 | 552 | 610 | 672 | 628 | 623 | 704 | 746 | 688 | 673 | 756 | 746 | 718 |
| Expenses | 362 | 346 | 340 | 320 | 366 | 358 | 348 | 333 | 386 | 326 | 359 | 362 | 428 | 357 | 366 | 375 | 435 | 361 | 396 | 355 | 352 | 356 | 417 | 397 | 448 | 462 | 519 | 478 | 490 | 537 | 579 | 528 | 526 | 570 | 597 | 559 | 552 | 608 | 595 | 589 |
| EBITDA | 37 | 63 | 53 | 53 | 66 | 82 | 67 | 53 | 63 | 44 | 75 | 72 | 129 | 62 | 76 | 79 | 93 | 67 | 84 | 71 | 45 | 81 | 91 | 86 | 51 | 68 | 71 | 65 | 63 | 73 | 93 | 100 | 97 | 134 | 149 | 129 | 121 | 147 | 151 | 130 |
| Operating Profit % | 9 % | 14 % | 13 % | 14 % | 15 % | 18 % | 15 % | 13 % | 14 % | 11 % | 16 % | 16 % | 17 % | 14 % | 16 % | 16 % | 16 % | 15 % | 17 % | 16 % | 10 % | 18 % | 17 % | 17 % | 10 % | 12 % | 11 % | 11 % | 10 % | 10 % | 12 % | 14 % | 15 % | 17 % | 18 % | 18 % | 16 % | 18 % | 19 % | 16 % |
| Depreciation | 8 | 7 | 7 | 7 | 10 | 7 | 7 | 7 | 8 | 8 | 7 | 8 | 8 | 7 | 7 | 7 | 10 | 13 | 13 | 13 | 14 | 13 | 13 | 14 | 15 | 14 | 14 | 14 | 15 | 13 | 13 | 12 | 12 | 12 | 12 | 13 | 13 | 13 | 14 | 14 |
| Interest | 3 | 16 | 15 | 15 | 15 | 16 | 16 | 14 | 10 | 10 | 12 | 12 | 14 | 9 | 9 | 8 | 9 | 8 | 8 | 9 | 8 | 6 | 5 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 31 | 40 | 31 | 31 | 41 | 60 | 43 | 32 | 45 | 27 | 56 | 52 | 107 | 45 | 60 | 64 | 74 | 46 | 63 | 49 | 23 | 61 | 73 | 68 | 33 | 50 | 55 | 47 | 45 | 57 | 76 | 84 | 82 | 121 | 135 | 115 | 107 | 132 | 136 | 114 |
| Tax | 4 | 15 | 12 | 12 | 30 | 15 | 12 | 11 | -63 | 2 | 10 | 19 | 31 | 12 | 14 | 12 | 7 | 9 | 9 | 4 | -3 | 11 | 13 | 15 | 6 | 10 | 11 | 9 | 8 | 9 | 11 | 17 | 23 | 25 | 31 | 24 | 29 | 31 | 31 | 26 |
| Net Profit | 27 | 25 | 19 | 19 | 11 | 45 | 31 | 21 | 107 | 24 | 46 | 33 | 76 | 34 | 46 | 51 | 67 | 37 | 54 | 45 | 27 | 50 | 60 | 53 | 27 | 40 | 44 | 38 | 37 | 48 | 65 | 67 | 59 | 96 | 104 | 91 | 78 | 102 | 105 | 87 |
| EPS in ₹ | 1.49 | 1.42 | 1.10 | 1.11 | 0.60 | 2.48 | 1.71 | 1.14 | 5.91 | 1.34 | 2.52 | 1.81 | 4.18 | 0.97 | 1.32 | 1.44 | 1.89 | 1.07 | 1.52 | 1.27 | 0.78 | 1.42 | 1.70 | 1.51 | 0.80 | 1.12 | 1.21 | 1.05 | 1.03 | 1.32 | 1.76 | 1.84 | 1.61 | 2.62 | 2.84 | 2.48 | 2.13 | 2.77 | 2.86 | 2.38 |
Jyothy Laboratories
328.70
-1.10
(-0.33%)
Market Cap
12,070.34 Cr
EPS
10.06
PE Ratio
32.54
Dividend Yield
1.06 %
Industry
Consumer Goods52 Week High
595.85
52 Week Low
310.20
PB Ratio
6.43
Debt to Equity
0.03
Sector
Household Products
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from11 analysts
Company News
View All News
Jyothy Labs to Sell Entire Stake in Jyothy Kallol Bangladesh5 days ago
The Board of Directors of Jyothy Labs has approved the sale of the company's entire equity stake in its subsidiary, Jyothy Kallol Bangladesh. This decision represents a significant corporate action that will likely impact the company's operations and financial structure in Bangladesh.
Jyothy Labs to Sell Entire Stake in Bangladesh Subsidiary5 days ago
Jyothy Labs' board has approved the sale of the company's entire equity stake in its subsidiary, Jyothy Kallol Bangladesh. This decision represents a significant corporate action that will likely impact the company's operations and financial structure in Bangladesh.
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
303.15 | 2,203.51 | 26.93 | 1,317.20 | -1.43 | 67 | 55.95 | 44.56 | |
645.35 | 662.02 | #1 2.27 | 20.30 | #1 156.96 | 266 | -72.70 | 54.42 | |
502.30 | 450.21 | 44.34 | 81.60 | -12.82 | 17 | -78.79 | 54.00 | |
414.80 | 311.10 | 2.53 | 650.70 | 12.68 | 15 | -308.62 | 36.94 | |
348.70 | 261.54 | 22.72 | 295.50 | 14.98 | 12 | -46.67 | 41.23 | |
182.58 | 199.86 | 3.10 | 70.30 | -8.58 | -196 | -28.06 | 39.13 | |
535.20 | 141.81 | 12.85 | 134.20 | 7.27 | 10 | 7.14 | 40.18 | |
11.97 | 108.52 | 27.75 | 19.80 | -1.98 | -0 | #1 2,400.00 | 57.38 | |
26.89 | 46.19 | 17.45 | 117.20 | - | 1 | -109.38 | 46.01 | |
Jyothy Laboratories this company | 328.70 | #1 12,070.34 | #9 32.54 | #1 2,810.70 | #4 11.29 | #1 369 | #4 -3.85 | 42.49 |
Growth Rate
Revenue Growth
11.29 %
Net Income Growth
54.07 %
Cash Flow Change
39.33 %
ROE
31.95 %
ROCE
33.44 %
EBITDA Margin (Avg.)
34.90 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,817 | 1,770 | 1,853 | 1,979 | 1,942 | 1,836 | 1,956 | 2,023 | 2,062 | 2,401 |
| Fixed Assets | 1,074 | 1,068 | 1,097 | 1,091 | 1,101 | 1,149 | 1,147 | 1,122 | 1,116 | 1,125 |
| Current Assets | 546 | 456 | 481 | 663 | 622 | 449 | 625 | 724 | 775 | 1,139 |
| Capital Work in Progress | 16 | 8 | 9 | 15 | 14 | 25 | 10 | 8 | 16 | 13 |
| Investments | 192 | 86 | 29 | 113 | 104 | 0 | 0 | 0 | 0 | 192 |
| Other Assets | 535 | 608 | 719 | 760 | 723 | 663 | 799 | 893 | 930 | 1,071 |
| Total Liabilities | 1,817 | 1,770 | 1,853 | 1,979 | 1,942 | 1,836 | 1,956 | 2,023 | 2,062 | 2,401 |
| Current Liabilities | 411 | 805 | 742 | 811 | 586 | 545 | 473 | 521 | 406 | 481 |
| Non Current Liabilities | 625 | 66 | 29 | 38 | 51 | 92 | 93 | 99 | 104 | 110 |
| Total Equity | 781 | 899 | 1,082 | 1,130 | 1,305 | 1,200 | 1,391 | 1,403 | 1,551 | 1,810 |
| Reserve & Surplus | 762 | 883 | 1,071 | 1,126 | 1,290 | 1,192 | 1,392 | 1,407 | 1,512 | 1,772 |
| Share Capital | 18 | 18 | 18 | 18 | 37 | 37 | 37 | 37 | 37 | 37 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 123 | -2 | 16 | 23 | 13 | -60 | 57 | 4 | 30 | -21 |
| Investing Activities | -26 | 108 | -17 | -74 | 30 | 73 | -129 | -32 | -48 | -344 |
| Operating Activities | 166 | 192 | 163 | 242 | 302 | 172 | 402 | 203 | 329 | 458 |
| Financing Activities | -18 | -302 | -130 | -145 | -319 | -304 | -216 | -167 | -251 | -135 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % | 62.89 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 16.43 % | 15.10 % | 15.10 % | 14.35 % |
| DIIs | 16.23 % | 15.95 % | 15.53 % | 17.12 % | 15.69 % | 16.93 % | 16.26 % | 17.14 % | 16.82 % | 15.36 % | 13.94 % | 13.66 % | 13.29 % | 14.36 % | 15.27 % | 15.26 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 6.38 % | 7.21 % | 7.09 % | 7.48 % | 8.09 % | 6.38 % | 5.88 % | 5.71 % | 5.60 % | 6.62 % | 6.87 % | 7.11 % | 6.07 % | 6.34 % | 5.91 % | 6.61 % |
| Others | 14.50 % | 13.95 % | 14.49 % | 12.51 % | 13.33 % | 13.80 % | 14.97 % | 14.27 % | 14.69 % | 15.13 % | 16.30 % | 16.35 % | 1.32 % | 1.31 % | 0.83 % | 0.89 % |
| No of Share Holders | 0 | 1,18,542 | 1,29,673 | 1,38,449 | 1,48,329 | 1,46,657 | 1,38,767 | 1,33,207 | 1,26,618 | 1,27,003 | 1,39,188 | 1,63,880 | 1,50,093 | 1,59,996 | 1,63,046 | 1,94,753 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 6 | 0.5 | 3 | 3 | 4 | 2.5 | 3 | 3.5 | 0.00 |
| Dividend Yield (%) | 0.00 | 3.03 | 0.27 | 3.25 | 2.19 | 2.71 | 1.32 | 0.68 | 1.06 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Closure of Trading Window
4 days ago
4 days agoIntimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20154 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
5 days agoAnnouncement Under Regulation 305 days ago
5 days agoBoard Meeting Outcome for Board Meeting Outcome Without Intimation5 days ago
5 days agoDisclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 20116 days ago
6 days agoDisclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 20116 days ago
6 days agoIntimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015Mar 19, 2025
Mar 19, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 10, 2025
Mar 10, 2025Announcement Under Regulation 30 (LODR)- Product Launch Mar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Feb 28, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 21, 2025
Feb 21, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Feb 06, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 03, 2025
Feb 03, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 02, 2025
Feb 02, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 01, 2025
Feb 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 31, 2025
Jan 31, 2025Integrated Filing (Financial)Jan 31, 2025
Jan 31, 2025Announcement Under Regulation 30 (LODR)- Product LaunchJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 31, 2025
Jan 31, 2025Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 31, 2025
Jan 31, 2025Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 31, 2025
Jan 31, 2025Disclosure Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 27, 2025
Jan 27, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Jan 27, 2025
Jan 27, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 27, 2025
Jan 27, 2025Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jan 20, 2025
Jan 20, 2025Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Jan 20, 2025
Jan 20, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2025
Jan 17, 2025Board Meeting Intimation for Notice Of The Board Meeting To Consider And Approve Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024.Jan 15, 2025
Jan 15, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 07, 2025
Jan 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 16, 2024
Dec 16, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 13, 2024
Dec 13, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 04, 2024
Dec 04, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 03, 2024
Dec 03, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 02, 2024
Dec 02, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 28, 2024
Nov 28, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2024
Nov 27, 2024Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 26, 2024
Nov 26, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2024
Nov 25, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 21, 2024
Nov 21, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 21, 2024
Nov 21, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 21, 2024
Nov 21, 2024Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 21, 2024
Nov 21, 2024Technical Indicators
RSI(14)
Neutral 42.49
ATR(14)
Less Volatile 12.14
STOCH(9,6)
Neutral 41.55
STOCH RSI(14)
Neutral 36.01
MACD(12,26)
Bullish 1.48
ADX(14)
Weak Trend 24.78
UO(9)
Bearish 42.18
ROC(12)
Downtrend And Accelerating -1.56
WillR(14)
Neutral -74.86
About Jyothy Laboratories
Jyothy Laboratories Ltd is an FMCG company founded in 1983 and incorporated in 1992. It manufactures and markets products in fabric care, dishwashing, household insecticides, and personal care categories. The company operates 25 manufacturing plants across 21 locations in India, with several ISO 9001-2015 certified units. Jyothy Labs' products are available in over 2.8 million outlets through various distribution channels. The company is divided into segments including Fabric Care, Dishwashing, Household Insecticides, Personal Care, and Others. Key brands include Ujala, Maxo, Exo, Margo, and Henko. The company has expanded through acquisitions, joint ventures, and product launches. In 2023, it merged with its wholly-owned subsidiary Jyothy Fabricare Services Limited. Jyothy Kallol Bangladesh Limited is a subsidiary of the company.
Listing Date
19 Dec, 2007(17 Years,
40 days)
Chairperson NameM R Jyothy
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
